Absolute contraindications include personal or family history of medullary thyroid carcinoma (MTC), Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), previous serious hypersensitivity to semaglutide or formulation components, pregnancy (the medication should be discontinued at least 2 months before planned conception), and breastfeeding due to insufficient data on excretion in human milk
Research-Grade Semaglutide vs Health CanadaApproved Drug Products The research-grade material supplied by Koi Peptides Canada is a chemically synthesized reference compound for in vitro laboratory study
Clinical teams may request cultures or advise empiric treatment
Semaglutide: A Breakthrough in Effective Weight Loss Ose Okojie Jun 26, 2024 2 min read Updated: Jul 6, 2024 Semaglutide: A Breakthrough in Effective Weight Loss As a healthcare professional with extensive experience in weight management and hormone therapy, I've seen firsthand how challenging weight loss can be for many patients
During 72 weeks of treatment, people taking tirzepatide at doses of 5, 10, or 15 mg lost an average of 15.0%, 19.5%, and 20.9%, respectively, compared with just 3.1% in people taking a placebo